Archer Daniels Midland (ADM) Q1 Earnings Surpass Estimates
📈 ADM reported Q1 earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.66 per share by 8.12%.
📊 Year-over-year adjusted earnings increased from $0.70 to $0.71, while revenue of $20.49 billion missed estimates by 2.93%.
🏆 The company has surpassed consensus EPS estimates in three out of the last four quarters.
📈 ADM shares have gained approximately 32.7% year-to-date compared to the S&P 500's gain of 5.2%.
💡 Future stock performance depends heavily on management's commentary and trends in earnings estimate revisions.
✅ The favorable estimate revision trend ahead of the report has translated into a Zacks Rank #2 (Buy) for the stock.
🔮 The current consensus EPS estimate for the coming quarter is $1.04 on revenues of $21.88 billion.
💰 For the full fiscal year, the consensus EPS estimate stands at $4.42 with revenues expected to be $84.29 billion.
⚠️ Investors should note that the Agriculture - Operations industry is currently ranked in the bottom 36% of Zacks industries.
🆓 Bioceres Crop (BIOX), another company in the same industry, is yet to report its Q1 results for the quarter ended March 2026.
❌ Analysts expect Bioceres Crop to post a quarterly loss of $0.05 per share and revenues down 8.6% year-over-year.
📝 These reports originate from Zacks Investment Research, which offers free stock analysis reports for ADM and BIOX.
👥 Access to detailed portfolio information requires signing in to the Zacks website.
- Archer Daniels Midland posted quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.66 per share by 8.12%.
- The company has surpassed consensus EPS estimates four times over the last four quarters, demonstrating a strong track record of meeting or exceeding analyst expectations.
- Shares have added approximately 32.7% since the beginning of the year, significantly outperforming the S&P 500's gain of 5.2%.
- Ahead of this earnings release, the estimate revisions trend for ADM was favorable, supporting its current Zacks Rank #2 (Buy) rating which suggests expected near-term outperformance.
- ADM's quarterly revenues of $20.49 billion missed the Zacks Consensus Estimate by 2.93%, marking the third time out of the last four quarters that revenue expectations were not met.
- The stock has topped consensus revenue estimates only once over the last four quarters, indicating an inconsistency in meeting top-line growth targets compared to its strong earnings beat.
- The Agriculture - Operations industry is currently ranked in the bottom 36% of the Zacks industries, posing a significant headwind that could limit the company's ability to outperform despite individual earnings surprises.
- A peer competitor, Bioceres Crop (BIOX), is expected to post a quarterly loss of $0.05 per share with revenues down 8.6%, signaling broader challenges within the agribusiness sector that may impact ADM's outlook.